ADCT
Adc Therapeutics SA

1,246
Mkt Cap
$508.28M
Volume
3.00
52W High
$4.80
52W Low
$1.05
PE Ratio
-2.77
ADCT Fundamentals
Price
$4.02
Prev Close
$3.92
Open
$3.92
50D MA
$3.74
Beta
1.51
Avg. Volume
739,238.70
EPS (Annual)
-$1.62
P/B
-1.90
Rev/Employee
$267,309.43
$65.48
Loading...
Loading...
News
all
press releases
ADC Therapeutics SA (NYSE:ADCT) Given Consensus Recommendation of "Moderate Buy" by Brokerages
Shares of ADC Therapeutics SA (NYSE:ADCT - Get Free Report) have received an average rating of "Moderate Buy" from the six analysts that are covering the stock, Marketbeat.com reports. One equities...
MarketBeat·6d ago
News Placeholder
More News
News Placeholder
ADC Therapeutics (NYSE:ADCT) Trading Down 4.5% - Here's What Happened
ADC Therapeutics (NYSE:ADCT) Trading Down 4.5% - Here's Why...
MarketBeat·7d ago
News Placeholder
ADC Therapeutics (NYSE:ADCT) Stock Price Down 4.5% - Here's Why
ADC Therapeutics (NYSE:ADCT) Stock Price Down 4.5% - What's Next...
MarketBeat·7d ago
News Placeholder
$170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium
$170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium $170B Patent Cliff Ignites Biotech Deal Wave: Late-Stage Platforms Command Premium PR Newswire VANCOUVER, BC, Jan...
PR Newswire·14d ago
News Placeholder
Has ADC Therapeutics (ADCT) Outpaced Other Medical Stocks This Year?
Here is how ADC Therapeutics SA (ADCT) and Assertio (ASRT) have performed compared to their sector so far this year.
Zacks·14d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC...
PR Newswire·22d ago
News Placeholder
Short Interest in ADC Therapeutics SA (NYSE:ADCT) Drops By 47.2%
ADC Therapeutics SA (NYSE:ADCT - Get Free Report) saw a large decline in short interest in the month of December. As of December 31st, there was short interest totaling 3,573,570 shares, a decline of...
MarketBeat·28d ago
News Placeholder
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC Therapeutics SA - ADCT INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADC...
PR Newswire·29d ago
News Placeholder
Are Medical Stocks Lagging ADC Therapeutics (ADCT) This Year?
Here is how ADC Therapeutics SA (ADCT) and Agenus (AGEN) have performed compared to their sector so far this year.
Zacks·1mo ago
News Placeholder
ADC Therapeutics SA (NYSE:ADCT) Given Consensus Recommendation of "Moderate Buy" by Brokerages
ADC Therapeutics SA (NYSE:ADCT - Get Free Report) has earned an average rating of "Moderate Buy" from the six brokerages that are currently covering the company, Marketbeat.com reports. One...
MarketBeat·1mo ago
<
1
2
...
>

Latest ADCT News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.